Status:
COMPLETED
Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
This is a randomized, single-site pilot study incorporating one control group. This research involves an exercise group and a non-exercise group (control group). The patients who are in the exercise ...
Detailed Description
The exercise protocol will consist of activities including walking/running up to a mile, calisthenics (jumping jacks, short relays, rapid punches) and light (no greater than 5 pounds) weight lifting. ...
Eligibility Criteria
Inclusion
- Receiving neoadjuvant chemotherapy for breast cancer at one of the UT Southwestern hospitals or affiliates (Simmons Cancer Center, Parkland Hospital)
- No evidence of metastatic disease as confirmed by routine staging
- 18 - 70 year old female
- Karnofsky score \>80%
- Body Mass Index \>25 kg/m2
- Able to speak, read and understand the English language
- Ability to understand and willingness to sign a written informed consent document
- All races and ethnicities will be eligible.
Exclusion
- Unable to speak, read and understand the English language
- Patients may not be involved in other trials evaluating the efficacy of neoadjuvant therapy
- Insulin-dependent diabetic patients.
- Known to be pregnant or planning to become pregnant during the study.
- Subjects are prohibited from being on other cancer treatments aside from what their treating medical oncologist has prescribed, primarily additional chemotherapies.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2018
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01411787
Start Date
March 1 2009
End Date
April 3 2018
Last Update
May 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390